Literature DB >> 16713069

Interview with Jack Schalken. PCA3 and its use as a diagnostic test in prostate cancer. Interview by Christine McKillop.

Jack Schalken.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16713069     DOI： 10.1016/j.eururo.2006.04.021

Source DB:  PubMed          Journal:  Eur Urol        ISSN： 0302-2838            Impact factor:   20.096


× No keyword cloud information.
  5 in total

1.  [Molecular genetic markers for prostate cancer. Evidence in fine needle biopsies for improved confirmation of the diagnosis].

Authors:  S Schneider; S Voigt; S Füssel; A Lohse-Fischer; S Tomasetti; M Haase; R Koch; G B Baretton; M-O Grimm; M Wirth
Journal:  Urologe A       Date:  2008-09       Impact factor: 0.639

Review 2.  Biomarkers in prostate cancer: new era and prospective.

Authors:  Amrallah A Mohammed
Journal:  Med Oncol       Date:  2014-07-22       Impact factor: 3.064

Review 3.  The PCA3 test for guiding repeat biopsy of prostate cancer and its cut-off score: a systematic review and meta-analysis.

Authors:  Yong Luo; Xin Gou; Peng Huang; Chan Mou
Journal:  Asian J Androl       Date:  2014 May-Jun       Impact factor: 3.285

4.  Electrochemical and optical detection and machine learning applied to images of genosensors for diagnosis of prostate cancer with the biomarker PCA3.

Authors:  Valquiria C Rodrigues; Juliana C Soares; Andrey C Soares; Daniel C Braz; Matias Eliseo Melendez; Lucas C Ribas; Leonardo F S Scabini; Odemir M Bruno; Andre Lopes Carvalho; Rui Manuel Reis; Rafaela C Sanfelice; Osvaldo N Oliveira
Journal:  Talanta       Date:  2020-08-07       Impact factor: 6.057

5.  PCA3 noncoding RNA is involved in the control of prostate-cancer cell survival and modulates androgen receptor signaling.

Authors:  Luciana Bueno Ferreira; Antonio Palumbo; Kivvi Duarte de Mello; Cinthya Sternberg; Mauricio S Caetano; Felipe Leite de Oliveira; Adriana Freitas Neves; Luiz Eurico Nasciutti; Luiz Ricardo Goulart; Etel Rodrigues Pereira Gimba
Journal:  BMC Cancer       Date:  2012-11-06       Impact factor: 4.430
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.